UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Autoimmune diseases in microscopic colitis: A Danish nationwide case–control study

Alimentary pharmacology & therapeutics, 2021-12, Vol.54 (11-12), p.1454-1462

2021

Link zum Volltext

Verfügbarkeit prüfen

All‐cause and cause‐specific mortality in microscopic colitis: a Danish nationwide matched cohort study

Alimentary pharmacology & therapeutics, 2020-07, Vol.52 (2), p.319-328

2020

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory bowel disease and risk of coronary heart disease

Trends in cardiovascular medicine, 2015-11, Vol.25 (8), p.699-704

2015

Link zum Volltext

Verfügbarkeit prüfen

Risk of cancer in patients with bile acid diarrhoea: a Danish nationwide matched cohort study

BMJ open gastroenterology, 2024-04, Vol.11 (1), p.e001340

2024

Link zum Volltext

Verfügbarkeit prüfen

Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease

JAMA : the journal of the American Medical Association, 2014-06, Vol.311 (23), p.2406

2014

Link zum Volltext

Verfügbarkeit prüfen

Association between tumour necrosis factor-α inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study

BMJ (Online), 2015-06, Vol.350, p.h2809

2015

Link zum Volltext

Verfügbarkeit prüfen

Risk of infections associated with biological treatment in inflammatory bowel disease

World journal of gastroenterology : WJG, 2014-11, Vol.20 (43), p.16014-16019

2014

Link zum Volltext

Verfügbarkeit prüfen

Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study

Gut, 2018-07, Vol.67 (7), p.1261

2018

Link zum Volltext

Verfügbarkeit prüfen

Reduced risk of UC in families affected by appendicitis: a Danish national cohort study

Gut, 2017-08, Vol.66 (8), p.1398

2017

Link zum Volltext

Verfügbarkeit prüfen

Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases

Clinical gastroenterology and hepatology, 2024-01, Vol.22 (1), p.135-143.e8

2024

Link zum Volltext

Verfügbarkeit prüfen

Ehealth:Low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome

World journal of gastroenterology : WJG, 2014-11, Vol.20 (43), p.16215-16226

2014

Link zum Volltext

Verfügbarkeit prüfen

Increased Risk of Inflammatory Bowel Disease in Families with Tonsillectomy: A Danish National Cohort Study

Epidemiology (Cambridge, Mass.), 2019-03, Vol.30 (2), p.256

2019

Link zum Volltext

Verfügbarkeit prüfen

Risk of cardiovascular disease in inflammatory bowel disease

World journal of gastrointestinal pathophysiology, 2014-08, Vol.5 (3), p.359-365

2014

Link zum Volltext

Verfügbarkeit prüfen

Risk of Demyelinating Diseases in the Central Nervous System in Patients With Inflammatory Bowel Disease Treated With Tumor Necrosis Factor Inhibitors

JAMA internal medicine, 2015-12, Vol.175 (12), p.1990

2015

Link zum Volltext

Verfügbarkeit prüfen

Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet

World journal of gastroenterology : WJG, 2014-06, Vol.20 (21), p.6680-6684

2014

Link zum Volltext

Verfügbarkeit prüfen

Higher Risk of Hospitalization and Serious Infection Among Patients With Ulcerative Colitis Treated with Adalimumab, Compared with Infliximab, in a Nationwide Study

Clinical gastroenterology and hepatology, 2016-11, Vol.15 (8), p.1218-1225.e7

2016

Link zum Volltext

Verfügbarkeit prüfen

Has the risk of colorectal cancer in inflammatory bowel disease decreased?

World journal of gastroenterology : WJG, 2013-11, Vol.19 (43), p.7561-7568

2013

Link zum Volltext

Verfügbarkeit prüfen

Anti-Tumor Necrosis Factor Treatment Does Not Decrease the Risk of Type 2 Diabetes in Patients With Inflammatory Bowel Disease

Clinical gastroenterology and hepatology, 2023-11, Vol.21 (12), p.3182-3184.e3

2023

Link zum Volltext

Verfügbarkeit prüfen

Mo1900 – TNF-α Inhibitors and Risk of Type 2 Diabetes in Patients with Inflammatory Bowel Disease

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-879-S-879

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Infliximab and Adalimumab in Biologic-Naive Patients With Ulcerative Colitis: A Nationwide Danish Cohort Study

Clinical gastroenterology and hepatology, 2017-08, Vol.15 (8), p.1218-1225.e7

2017

Link zum Volltext

Verfügbarkeit prüfen

Su1850 RISK OF INCIDENT PARADOXICAL IMMUNE-MEDIATED INFLAMMATORY DISEASES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI-TNF THERAPIES: A NATIONWIDE DANISH COHORT STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-674-S-674

2020

Link zum Volltext

Verfügbarkeit prüfen

The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection

The European respiratory journal, 2022-04, Vol.59 (4), p.2100769

2022

Link zum Volltext

Verfügbarkeit prüfen

Differences in epidemiological features between ulcerative colitis and Crohn’s disease: The early life-programmed versus late dysbiosis hypothesis

Medical hypotheses, 2018-06, Vol.115, p.19-21

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparative Effectiveness and Safety of Infliximab and Adalimumab in Inflammatory Bowel Diseases: A Nationwide Danish Cohort Study: 2016 ACG Governors Award for Excellence in Clinical Research: 568

The American journal of gastroenterology, 2016-10, Vol.111, p.S260

2016

Link zum Volltext

Verfügbarkeit prüfen

Differences in epidemiological features between ulcerative colitis and Crohn’s disease: The early life-programmed versus late dysbiosis hypothesis

Medical hypotheses, 2018-06, Vol.115, p.19-21

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Autoimmune diseases in microscopic colitis: A Danish nationwide case–control study

All‐cause and cause‐specific mortality in microscopic colitis: a Danish nationwide matched cohort study

Inflammatory bowel disease and risk of coronary heart disease

Risk of cancer in patients with bile acid diarrhoea: a Danish nationwide matched cohort study

Association between tumor necrosis factor-α antagonists and risk of cancer in patients with inflammatory bowel disease

Association between tumour necrosis factor-α inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study

Risk of infections associated with biological treatment in inflammatory bowel disease

Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study

Reduced risk of UC in families affected by appendicitis: a Danish national cohort study

Tumor Necrosis Factor Inhibitors in Inflammatory Bowel Disease and Risk of Immune Mediated Inflammatory Diseases

Ehealth:Low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome

Increased Risk of Inflammatory Bowel Disease in Families with Tonsillectomy: A Danish National Cohort Study

Risk of cardiovascular disease in inflammatory bowel disease

Risk of Demyelinating Diseases in the Central Nervous System in Patients With Inflammatory Bowel Disease Treated With Tumor Necrosis Factor Inhibitors

Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet

Higher Risk of Hospitalization and Serious Infection Among Patients With Ulcerative Colitis Treated with Adalimumab, Compared with Infliximab, in a Nationwide Study

Has the risk of colorectal cancer in inflammatory bowel disease decreased?

Anti-Tumor Necrosis Factor Treatment Does Not Decrease the Risk of Type 2 Diabetes in Patients With Inflammatory Bowel Disease

Mo1900 – TNF-α Inhibitors and Risk of Type 2 Diabetes in Patients with Inflammatory Bowel Disease

Comparison of Infliximab and Adalimumab in Biologic-Naive Patients With Ulcerative Colitis: A Nationwide Danish Cohort Study

Su1850 RISK OF INCIDENT PARADOXICAL IMMUNE-MEDIATED INFLAMMATORY DISEASES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI-TNF THERAPIES: A NATIONWIDE DANISH COHORT STUDY

The effect of immunosuppressants on the prognosis of SARS-CoV-2 infection

Differences in epidemiological features between ulcerative colitis and Crohn’s disease: The early life-programmed versus late dysbiosis hypothesis

Comparative Effectiveness and Safety of Infliximab and Adalimumab in Inflammatory Bowel Diseases: A Nationwide Danish Cohort Study: 2016 ACG Governors Award for Excellence in Clinical Research: 568

Differences in epidemiological features between ulcerative colitis and Crohn’s disease: The early life-programmed versus late dysbiosis hypothesis

Suchergebnisse filtern